Your browser doesn't support javascript.
loading
New alternatives to holder pasteurization in processing donor milk in human milk banks.
Moro, Guido E; Girard, Melissa; Peila, Chiara; Garcia, Nadia; Escuder-Vieco, Diana; Keller, Kristin; Cassidy, Tanya; Bertino, Enrico; Boquien, Clair-Yves; Buffin, Rachel; Calvo, Javier; Gaya, Antoni; Gebauer, Corinna; Lamireau, Delphine; Lembo, David; Picaud, Jean-Charles; Wesolowska, Aleksandra; Arslanoglu, Sertac; Cavallarin, Laura; Giribaldi, Marzia.
Afiliação
  • Moro GE; Associazione Italiana delle Banche del Latte Umano Donato (AIBLUD), Milan, Italy.
  • Girard M; Medical Affairs and Innovation, Héma-Québec, Québec, QC, Canada.
  • Peila C; Neonatal Unit, Department of Public Health and Pediatrics, University of Turin, Turin, Italy.
  • Garcia N; Banco Regional de Leche Materna Aladina-MGU, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Escuder-Vieco D; Banco Regional de Leche Materna Aladina-MGU, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Keller K; Banco Regional de Leche Materna Aladina-MGU, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Cassidy T; Kathleen Lonsdale Health Research Institute, Maynooth University, Maynooth, Ireland.
  • Bertino E; Neonatal Unit, Department of Public Health and Pediatrics, University of Turin, Turin, Italy.
  • Boquien CY; Nantes Université, INRAE, UMR 1280, PhAN, CRNH-OUEST, Nantes, France.
  • Buffin R; Neonatology UnitCroix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France.
  • Calvo J; Rhône-Alpes-Auvergne Regional Human Milk Bank, Croix-Rousse University Hospital, Hospices Civils de Lyon, Lyon, France.
  • Gaya A; Group of Cell Therapy and Tissue Engineering (TERCIT), Fundació Banc de Sang i Teixits de les Illes Balears (FBSTIB), Research Institute on Health Sciences (IUNICS) and Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
  • Gebauer C; Group of Cell Therapy and Tissue Engineering (TERCIT), Fundació Banc de Sang i Teixits de les Illes Balears (FBSTIB), Research Institute on Health Sciences (IUNICS) and Health Research Institute of the Balearic Islands (IdISBa), Palma, Spain.
  • Lamireau D; Abteilung Neonatologie Klinik und Poliklinik für Kinder und Jugendliche, Leipzig, Germany.
  • Lembo D; Human Milk Bank of University Hospital of Bordeaux, Lamireau, France.
  • Picaud JC; Laboratory of Molecular Virology and Antiviral Research, Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
  • Wesolowska A; Department of Neonatology, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Lyon, France.
  • Arslanoglu S; CarMen Laboratory, INSERM, INRA, Université Claude Bernard Lyon1, Lyon, France.
  • Cavallarin L; Laboratory of Human Milk and Lactation Research at Milk Bank in Holy Family Hospital, Department of Medical Biology, Faculty of Health Science, Medical University of Warsaw, Warsaw, Poland.
  • Giribaldi M; Division of Neonatology, Department of Pediatrics, Istanbul Medeniyet University, Istanbul, Türkiye.
Front Nutr ; 11: 1409381, 2024.
Article em En | MEDLINE | ID: mdl-38988859
ABSTRACT
Infectious and toxicological risks are the main potential hazards that operators of Human Milk Banks (HMBs) encounter and must eliminate. HMBs are trying to implement procedures that allow to manage and sanitize human milk without altering significantly its nutritional and biologically protective components, obtaining a product characterized by a valid balance between safety and biological quality. The history of human milk processing is linked to the origins of HMBs themselves. And although other forms of sterilization were used originally, pasteurization soon became the recognized most effective means for sanitizing milk all the milk that arrives at the HMB must be pasteurized. Holder pasteurization (HoP) is the most used methodology, and it is performed using low temperature and long time (+62.5°C for 30 min). With HoP some bioactive milk components are lost to varying degrees, but many other precious bioactive compounds are completely or partially preserved. To improve the quality of human milk processed by HMBs, maintaining in the meantime the same microbiological safety offered by HoP, new technologies are under evaluation. At present, High-Temperature Short-Time pasteurization (HTST) and High-Pressure Processing are the most studied methodologies. HTST is already utilized in some HMBs for daily practical activity and for research purposes. They seem to be superior to HoP for a better preservation of some nutritional and biologically protective components. Freeze-drying or lyophilization may have advantages for room temperature storage and transportation. The aim of this study is to evaluate the advancement regarding the processing of DHM with a literature search from 2019 to 2022. The effects of the new technologies on safety and quality of human milk are presented and discussed. The new technologies should assure microbiological safety of the final product at least at the same level as optimized HoP, with an improved preservation of the nutritional and bioactive components of raw human milk.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália